Congenital Hematological Disorder Completed Phase 2 Trials for Coagulation factor VIIa Recombinant Human (DB00036)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03196284A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With InhibitorsTreatment
NCT00951405Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With InhibitorsPrevention
NCT00486278Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsTreatment